Emergence of Acquired Dolutegravir Resistance in Treatment-Experienced People with HIV in Lesotho
SSRN Electronic Journal2024
Citations Over Time
Nadine Tschumi, Blaise Lukau, Katleho Tlali, Lipontso Motaboli, Mpho Kao, Mathebe Kopo, Kathrin Hänggi, Moleboheng Mokebe, Klaudia Naegele, Irene Ayakaka, Karoline Leuzinger, Jennifer Anne Brown, Niklaus Daniel Labhardt
Related Papers
- → End resistance to dolutegravir roll-out(2020)33 cited
- → Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance(2017)20 cited
- → Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial(2021)14 cited
- → Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations(2024)4 cited
- → TIVICAY (Dolutegravir)(2017)